Accelerated approval history

Accelerated approval history

Studies reviewed
Product Indication Approved Company (total patients) (A)
Arimidex anastrozole Adjuvant treatment for hormone receptor-positive early breast cancer 9/5/02 AstraZeneca 1 (9,366)
Bexxar tositumomab

Read the full 281 word article

How to gain access

Continue reading with a
two-week free trial.